RETRACTED: 3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis (Retracted article. See vol. 23, pg. 272, 2015)

被引:4
作者
Shirai, Junya [1 ]
Nakamura, Minoru [1 ]
Tarui, Naoki [1 ]
Hashimoto, Tadatoshi [1 ]
Ikeura, Yoshinori [1 ]
机构
[1] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan
关键词
Tachykinin; NK1; receptor; 3-Benzhydryl-4-piperidone; G-Protein coupled receptor (GPCR); 1,1-Diphenylmethane moiety; SUBSTANCE-P; POTENT;
D O I
10.1016/j.bmc.2011.07.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel 3-benzhydryl-4-piperidone derivatives were identified as potent tachykinin neurokinin-1 (NK1) receptor antagonists. An efficient and versatile synthesis of this series was achieved with a coupling reaction of 1-benzylpiperidones with benzhydryl bromides or benzhydrols in the presence of trifluoromethanesulfonate and a condensation reaction of piperidones with benzyl alcohols using ethyl o-phenylenephosphate. The 3-benzhydryl-4-piperidone skeleton, which has a 1,1-diphenylmethane moiety that is a known privileged substructure targeting G-protein coupled receptors, can be used for chemical library synthesis because of chemical accessibility and diversity. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5175 / 5182
页数:8
相关论文
共 20 条
[1]  
CASCIERI MA, 1992, MOL PHARMACOL, V42, P458
[2]   AMINO-ACID SEQUENCE OF SUBSTANCE P [J].
CHANG, MM ;
LEEMAN, SE ;
NIALL, HD .
NATURE-NEW BIOLOGY, 1971, 232 (29) :86-+
[3]  
Chemical Computing Group, 2009, MOL OP ENV VERS 2009
[4]   DIRECT EVIDENCE THAT CAPSAICIN-INDUCED PLASMA-PROTEIN EXTRAVASATION IS MEDIATED THROUGH TACHYKININ NK1 RECEPTORS [J].
EGLEZOS, A ;
GIULIANI, S ;
VITI, G ;
MAGGI, CA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 209 (03) :277-279
[5]   Neurokinin receptor antagonists [J].
Elliott, J ;
Seward, EM .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (01) :43-54
[6]   METHODS FOR DRUG DISCOVERY - DEVELOPMENT OF POTENT, SELECTIVE, ORALLY EFFECTIVE CHOLECYSTOKININ ANTAGONISTS [J].
EVANS, BE ;
RITTLE, KE ;
BOCK, MG ;
DIPARDO, RM ;
FREIDINGER, RM ;
WHITTER, WL ;
LUNDELL, GF ;
VEBER, DF ;
ANDERSON, PS ;
CHANG, RSL ;
LOTTI, VJ ;
CERINO, DJ ;
CHEN, TB ;
KLING, PJ ;
KUNKEL, KA ;
SPRINGER, JP ;
HIRSHFIELD, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (12) :2235-2246
[7]   Substance P:: a pioneer amongst neuropeptides [J].
Hökfelt, T ;
Pernow, B ;
Wahren, J .
JOURNAL OF INTERNAL MEDICINE, 2001, 249 (01) :27-40
[8]  
IKEURA Y, Patent No. 1553084
[9]  
Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO
[10]  
2-5